Cover Image
12 April 2021
General Pitfalls in Imaging of Patients With Cirrhosis
Ali Morshid, Victoria Chernyak, Alice W. Fung, Khaled M. Elsayes – 12 April 2021
Imaging Modalities in Pediatric NAFLD
Suraj D. Serai, Jennifer Panganiban, Manish Dhyani, Andrew J. Degnan, Sudha A. Anupindi – 12 April 2021
LI‐RADS: Future Directions
Victoria Chernyak, Claude B. Sirlin – 12 April 2021
Hepatic Venous Pressure Gradient
Teodora Bochnakova – 12 April 2021
Hepatobiliary Manifestations of Whipple Disease
Gabriela Kuftinec, Amar R. Deshpande, Andres F. Carrion – 12 April 2021
LiverLearning®: 2021 Webinar: FY21 Peer Reviewed Cancer Research Program Funding Opportunities in Liver Cancer
The Peer Reviewed Cancer Research Program webinar will present funding opportunities for liver cancer through the Department of Defense. This webinar will cover topics including how to apply, what opportunities are available, as well as hints and tips on how to succeed in applying to the Department of Defense Congressionally Directed Medical Research Programs.Donna M. Kimbark Donna M. Kimbark, PhD currently serves as the Program Manager at the Congressionally Directed Medical Research Programs, U.S. Army Medical Research and Development Command. In 1996, Dr.
Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments
Leonardo Baiocchi, Shannon Glaser, Heather Francis, Lindsey Kennedy, Eric Felli, Gianfranco Alpini, Jordi Gracia‐Sancho – 9 April 2021 – The aging process is represented by the time‐dependent decay in physiologic functions of living beings. Major interest has been focused in recent years on the determinants of this progressive condition due to its correlative relationship with the onset of diseases. Several hallmark features have been observed in aging, such as genetic alterations, mitochondrial impairment, and telomere shortening.
Minimally Invasive Living Donor Liver Transplantation: Pure Laparoscopic Explant Hepatectomy and Graft Implantation Using Upper Midline Incision
Kyung‐Suk Suh, Suk Kyun Hong, Kwangpyo Hong, Eui Soo Han, Su Young Hong, Sanggyun Suh, Jeong‐Moo Lee, YoungRok Choi, Nam‐Joon Yi, Kwang‐Woong Lee – 9 April 2021
Differences Between Infectious Disease Events in First Liver Transplant Versus Retransplantation in the Swiss Transplant Cohort Study
Katharina Kusejko, Dionysios Neofytos, Hans H. Hirsch, Pascal Meylan, Katia Boggian, Cedric Hirzel, Christian Garzoni, Roger D. Kouyos, Nicolas J. Mueller, Peter W. Schreiber, the Swiss Transplant Cohort Study – 9 April 2021 – Retransplantation after graft failure is increasingly performed, and inferior graft survival, patient survival, and quality of life has been reported. The role of infectious disease (ID) events in this less favorable outcome is unknown. We analyzed ID events after first liver transplantation (FLTpx) and retransplantation (reLTpx) in the Swiss Transplant Cohort Study.